Tenshi Pharmaceuticals Private Limited has increased its stake in Onesource Specialty Pharma Limited, acquiring 205,000 equity shares. This acquisition raises Tenshi’s total shareholding to 3,48,55,105 shares, representing 30.41% of the total equity. The shares were acquired through open market purchases, as disclosed on February 4, 2026.
Increased Shareholding in Onesource
Tenshi Pharmaceuticals Private Limited announced on February 4, 2026, that it has increased its stake in Onesource Specialty Pharma Limited (TC) by acquiring an additional 205,000 equity shares.
Details of the Acquisition
The acquisition was made through the open market. With this purchase, Tenshi Pharmaceuticals now holds a total of 3,48,55,105 shares in Onesource Specialty Pharma Limited.
Revised Shareholding Percentage
Following the acquisition of the additional shares, Tenshi Pharmaceuticals’ stake in Onesource Specialty Pharma Limited has increased to 30.41% of the total equity share capital. The total voting capital of Onesource Specialty Pharma Limited remains at 11,46,21,201 equity shares after the acquisition.
Source: BSE
